On May 1, 2026, Health Canada authorized a second generic semaglutide injection, filed by Canadian-based Apotex, and said it was reviewing seven other submissions from different companies
But Michaels says GLP-1s are different
A 2021 study even found that tooth loss, dry mouth, and having three or more oral problems as an older person are all tied to higher all-cause mortality
On the other hand, a person with more muscle mass may require a slightly longer needle for an intramuscular shot to reach the muscle effectively
Her experience echoes what a growing number of people are discovering: you dont always need the maximum dose to see real results
IGF-1 LR3 in humans There are no published Phase 2 or Phase 3 human RCTs evaluating IGF-1 LR3 for body composition, fat loss, or muscle accretion in healthy or metabolically compromised adults